TESAMORELIN 10 MG
SKU: CP_TESAMORELIN_10MG_3ML_VIAL
Catalog price · 1 item: US$89.00 (USD)
Product information
Nonclinical pharmacology
The page describes tesamorelin as a modified GHRH analogue designed to slow DPP-IV-mediated breakdown. In the cited rat and dog work, degradation in plasma was slower than for unmodified GHRH, and repeated exposure increased GH and IGF-1 measurements.
That work also reported reversible liver and kidney tissue changes, anemia and chemistry changes in dogs at sustained excessive GH/IGF-1 exposure. Other cited rat experiments combined antiretroviral regimens with calorie-rich diets and compared metabolic measurements, ECG indices and myocardial histology with and without tesamorelin. The reported differences belong to those animal protocols and do not demonstrate clinical effects of this vial.
Specifications
| SKU | CP_TESAMORELIN_10MG_3ML_VIAL |
|---|---|
| CATEGORY | Lyophilized Peptide |
| CAS | 901758-09-6 |
| VIAL SIZE | 3 mL |
| FORM | LYOPHILIZED POWDER (Acetate Salt) |
| MOLECULAR WEIGHT | 5135.9 g/mol |
| SEQUENCE | 44-aa GHRH analogue with N-terminal trans-3-hexenoyl modification |
| MOLECULAR FORMULA | C221H366N72O67S |
| ITEM ID | 78 |
| PURITY | 99%+ |
| CAS | 901758-09-6 |
| FORM | LYOPHILIZED POWDER (Acetate Salt) |
| DOSAGE | 10 MG |